Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000776605 | SCV000912221 | likely benign | Familial hypercholesterolemia | 2018-07-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002067336 | SCV002386061 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2023-02-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002067336 | SCV002800297 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2021-07-16 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV002067336 | SCV004835859 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004985126 | SCV005472629 | likely benign | Cardiovascular phenotype | 2024-08-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |